Zynex reports first quarter 2024 financial results

Q1 2024 revenue increased 10% to $46.5 million englewood, colo. , april 30, 2024 /prnewswire/ -- zynex, inc. (nasdaq: zyxi), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today reported its financial and operational results for the first quarter ended march 31, 2024.
ZYXI Ratings Summary
ZYXI Quant Ranking